Announced
Financials
Sources
Tags
Private Equity
Majority
Pending
Private
Acquisition
India
Single Bidder
Friendly
Cross Border
active pharmaceutical ingredients
Pharmaceuticals
Synopsis
Advent International, a private equity firm, agreed to acquire a majority stake in Avra Laboratories, an active pharmaceutical ingredients manufacturer, for $100m. “This acquisition is an important milestone towards our goal of creating a top five merchant API Platform in India and allows Advent to be present across the spectrum of generic and patented molecules, while adding marquee innovator pharma customers," Pankaj Patwari, Advent International India Managing Director.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.